149325-60-0

Basic information

• Product Name: tert-butyl 4-<3-(2-cyano-3-methoxy-2-cyclopentyl)-1-methylpropyl>benzoate
• Synonyms: tert-butyl 4-<3-(2-cyano-3-methoxy-2-cyclopentyl)-1-methylpropyl>benzoate
• CAS NO: 149325-60-0
• Molecular Weight: 355.477
• Mol File: 149325-60-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-<3-(2-cyano-3-methoxy-2-cyclopentyl)-1-methylpropyl>benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-<3-(2-cyano-3-methoxy-2-cyclopentyl)-1-methylpropyl>benzoate(149325-60-0)
• EPA Substance Registry System: tert-butyl 4-<3-(2-cyano-3-methoxy-2-cyclopentyl)-1-methylpropyl>benzoate(149325-60-0)

Safety Data

• Hazardous Substances Data: 149325-60-0(Hazardous Substances Data)

Upstream product

• 18107-18-1 diazomethyl-trimethyl-silane 
• 105580-41-4 4-acetylbenzoic acid tert-butyl ester 
• 149325-57-5 tert-butyl 4-(3-hydroxy-1-methylpropyl)benzoate 
• 149324-79-8 tert-butyl 4-(3-iodo-1-methylpropyl)benzoate 
• 170799-76-5 3-<4-(tert-butoxycarbonyl)phenyl>-3-methylpropionic acid 
• 170799-79-8 tert-butyl 4-(2-ethoxycarbonyl-1-methylethyl)benzoate 
• 170799-74-3 4-(3-Methanesulfonyloxy-1-methyl-propyl)-benzoic acid tert-butyl ester 

Downstream Products

• 1054687-13-6 diethyl N-<4-<3-(2,4-diamino-6,7-dihydro-5H-cyclopentapyrimidin-5-yl)-1-methylpropyl>benzoyl>-L-glutamate 
• 149325-61-1 4-<3-(2,4-diamino-6,7-dihydro-5H-cyclopentapyrimidin-5-yl)-1-methylpropyl>benzoic acid 
• 170799-58-3 tert-butyl 4-<3-(2,4-diamino-6,7-dihydro-5H-cyclopentapyrimidin-5-yl)-1-methylpropyl>benzoate 

Relevant articles and documents

Condensed pyrimidine derivative

A novel pyrimidine derivative having an excellent antitumor activity, which is represented by the following general formula (I) or a pharmacologically acceptable salt thereof: STR1 wherein R1 represents a hydroxyl or amino group; R2 represents a phenylene, pyridinediyl, thiendiyl, furandiyl or thiazoldiyl group, --CO2 R5 and --CO2 R6 may be the same or different from each other and each represents a carboxyl group or a carboxylic acid ester, the part STR2 A represents an oxygen atom, a group represented by the formula: STR3 (wherein R3 and R4 may be the same or different from each other and each represents a hydrogen or halogen atom or a hydrocarbon group which may be substituted, or alternatively R3 and R4 may be united to form an alkylidene group which may be substituted) or a group represented by the formula: STR4 (wherein R70 represents a hydrogen atom or a hydrocarbon group), and n is an integer of 1 to 3, provided that the compound in which R1 represents oxygen, and hydrogen is attached to nitrogen at 3-position is included in the above shown definition, a process for preparation the same, and an antitumor drug containing the same.